Exicure Inc (XCUR): Back to )6,70

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Exicure Inc (XCUR)

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	268
Posts	30554
Boards Moderated	0
Alias Born	08/14/2011

Re: georgie18 post# 438

Thursday, 12/11/2025 3:28:40 PM

Thursday, December 11, 2025 3:28:40 PM

Back to )6,70

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent XCUR News

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100) • GlobeNewswire Inc. • 04/22/2026 11:54:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:15:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:15:02 PM
Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions • GlobeNewswire Inc. • 04/02/2026 08:01:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 08:40:30 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:42:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:32:21 PM
Exicure, Inc. Reports Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/25/2026 08:18:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:25:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2026 09:25:41 PM
Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant • GlobeNewswire Inc. • 02/05/2026 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 09:29:08 PM
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/21/2026 06:21:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 05:46:19 PM
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings • GlobeNewswire Inc. • 01/21/2026 12:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2026 07:09:18 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 01:42:41 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2025 01:51:19 AM
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting • GlobeNewswire Inc. • 12/08/2025 09:30:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 04:50:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2025 09:52:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 09:17:16 PM

More XCUR News

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow